Anika Therapeutics (ANIK) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $15.36 +1.19%
Revenue Growth %: +3.5%
Financial Fact:
Research & development: 2.82M
Today's EPS Names:
CRMT, More
Revenue Growth %: +3.5%
Financial Fact:
Research & development: 2.82M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of ($0.12), $0.11 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $39.7 million versus the consensus estimate of $37.85 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- FactSet Research Systems (FDS) PT Raised to $253 at Jefferies
- SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
